| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32K | — | -98.5% |
| Cost of Revenue | $17K | — | -97.9% |
| Gross Profit | $15K | — | -98.9% |
| R&D Expense | $5.0M | — | +69.4% |
| SG&A Expense | $3.0M | — | -4.0% |
| Operating Income | -$4.4M | — | +35.1% |
| Income Tax | $0 | — | — |
| Net Income | -$4.3M | — | +35.7% |
| EPS (Basic) | -$0.12 | — | +53.8% |
| EPS (Diluted) | -$0.12 | — | +53.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.2M | +143.5% | -9.1% |
| Accounts Receivable | $157K | -86.1% | -95.6% |
| Inventory | $382K | -14.3% | -16.8% |
| Current Assets | $30.5M | +99.4% | -15.8% |
| Total Assets | $40.4M | +57.0% | -33.0% |
| Current Liabilities | $12.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.6M | — | -30.4% |
| Capital Expenditures | $613K | — | +99.7% |
| Investing Cash Flow | -$613K | — | -99.7% |
| Financing Cash Flow | $24.7M | — | -13.5% |
| Free Cash Flow | -$8.3M | — | -33.9% |
| +24.0% |
| Total Liabilities | $51.1M | -10.7% | +1.9% |
| Stockholders' Equity | -$10.7M | +66.0% | -204.6% |